2nd World Congress on Pharmacology & Toxicology will takes immense pleasure & feels honored in inviting the contributors across the globe to attend in Rome, Italy in Aug 16-18, 2018 and The Program is prepared to highlight the newest findings in pharmacology with the purpose of exchanging ideas and bringing together research scientists, academics, industry specialists, doctors, pharmacists and students of life sciences.
We hope that everyone will enjoy the scientific content of the Conference and your interaction with participants from different countries will stimulate a creative scientific atmosphere and promote new collaborations. Pharmacology and toxicology conference will help to raise awareness about the importance of drugs and effects of chemicals on humans, animals and other biological systems.
We are looking forward to meeting you at the exciting conference of high scientific level in the very beautiful city of Rome, Italy.
If you require any further information please do not hesitate to contact the conference Manager at
A diverse scientific collaboration has developed vascularized 3-D bioprinted liver tissue constructs, providing more precise drug toxicity testing and possibly providing tailored testing samples using a patient's own cells
APOSEC is a substance obtained from white blood corpuscles. Even during its preclinical development, it was demonstrated that the multifactorial agent can be used in heart attacks, strokes, spinal cord injuries and for healing wounds. This promising substance is now in the clinical phase of the approval process that will license it as a new drug for healing external wounds.
A new drug zeroes in on mutated nuclear receptors found in cancer and leaves normal proteins alone
Researchers have determined the most effective drug dose to help penguins in managed care fight off disease.
A new technique for evaluating drug safety is designed to be affordable and can detect stress on cells at earlier stages than conventional methods. It is the first with a fluorescent sensor that turns on when proteins begin to clump together -- an early sign of a process that occurs in Alzheimer's and other diseases.
The use of proton pump inhibitors does not increase the risk of Alzheimer's disease, shows a recent study from the University of Eastern Finland.
Copyrights © 2016-17 Innovinc Pvt Ltd All Rights Reserved